ClinVar Miner

Submissions for variant NM_001360.3(DHCR7):c.906C>T (p.Phe302=)

dbSNP: rs80338858
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000724362 SCV000232611 uncertain significance not provided 2018-02-20 criteria provided, single submitter clinical testing
GeneDx RCV000724362 SCV000536084 likely benign not provided 2021-10-04 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001086880 SCV001015133 likely benign Smith-Lemli-Opitz syndrome 2025-02-02 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001086880 SCV001271956 uncertain significance Smith-Lemli-Opitz syndrome 2017-09-19 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Ambry Genetics RCV002372104 SCV002688523 likely benign Inborn genetic diseases 2018-05-18 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
CeGaT Center for Human Genetics Tuebingen RCV000724362 SCV004699514 likely benign not provided 2024-01-01 criteria provided, single submitter clinical testing DHCR7: BP4, BP7
Natera, Inc. RCV001086880 SCV001460490 likely benign Smith-Lemli-Opitz syndrome 2020-09-16 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003937634 SCV004748000 likely benign DHCR7-related disorder 2019-07-08 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.